Device type · NQN
Microscope, Automated, Image Analysis, Immunohistochemistry,Operator Intervention,Nuclear Intensity & Percent Positivity
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
NQN
Pathology
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Microscope, Automated, Image Analysis, Immunohistochemistry,Operator Intervention,Nuclear Intensity & Percent Positivity
- Product code
- NQN
- Device class
- Class II
- Review panel
- Pathology
- Regulation
- 21 CFR 864.1860
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for NQN
Latest FDA decisions
Applied Spectral Imaging , Ltd.
K140957 · Decided Jan 15, 2015 · 276 days after receipt
Device type: Microscope, Automated, Image Analysis, Immunohistochemistry,Operator Intervention,Nuclear Intensity & Percent Positivity (NQN) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- uPath software 1.1 and uPath software 1.1 IVD-INSW, Material numbers 08991871001 and 09077332001Terminated
Z-0877-2021 · Started Nov 23, 2020
Reason given: When a user creates a measurement tool annotation in the uPath Enterprise software version 1.1, the measurement value is incorrectly calculated when the measurement is viewed in "Split View" viewing mode and the slides within the case are scanned at different magnifications.
Cause as FDA categorized it: Software design
Leica Biosystems Richmond Inc.
Z-1948-2016 · Started May 6, 2016
Reason given: An issue during the manufacturing process caused systems to have an improperly activated Windows 7 OS, even though a valid Windows 7 license was associated with each manufactured system.
Cause as FDA categorized it: Nonconforming Material/Component
Z-1040-2009 · Started Nov 6, 2008 · Posted by FDA Mar 24, 2009
Reason given: A change in the software to open up the software architecture to include other analytes other than Estrogen Receptor was made without FDA review and approval.
Cause as FDA categorized it: Software change control
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.